Sean D. Donevan
Pfizer (United States)(US)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Ion channel regulation and function, Epilepsy research and treatment, Pain Mechanisms and Treatments, Nicotinic Acetylcholine Receptors Study
Most-Cited Works
- → Ca2+ channel α2δ ligands: novel modulators of neurotransmission(2007)384 cited
- → GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses(1993)359 cited
- → Intracellular polyamines mediate inward rectification of Ca(2+)-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.(1995)231 cited
- → Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons.(1996)186 cited
- → Mechanism of action of the anticonvulsant felbamate: Opposing effects on N‐methyl‐D‐aspartate and γ‐aminobutyric acidA receptors(1994)184 cited
- → Acetoacetate, Acetone, and Dibenzylamine (a Contaminant in l‐(+)‐β‐Hydroxybutyrate) Exhibit Direct Anticonvulsant Actions in Vivo(2002)154 cited
- → Pregabalin is a potent and selective ligand for α2δ-1 and α2δ-2 calcium channel subunits(2011)148 cited
- → How Modeling and Simulation Have Enhanced Decision Making in New Drug Development(2005)143 cited
- → Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBQX in maximal electroshock and chemoconvulsant seizure models(1993)143 cited
- AMPA receptors in epilepsy and as targets for antiepileptic drugs.(1999)